Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2023-12-05 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission in South Korea. It specifically details the finalization of the issuance price for a capital increase (유상증자) by MedPacto. Since it involves the issuance of new shares and the finalization of capital structure terms, it falls under the 'Share Issue/Capital Change' category.
2023-12-05 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Investment Prospectus' (투자설명서) amendment (정정신고) filed by MedPacto. It details changes to the final issuance price of shares following a capital increase (유상증자). This document is a regulatory filing related to capital structure and financing, which falls under the 'Capital/Financing Update' category. It is not a report publication announcement because it contains the actual detailed financial and procedural data regarding the capital raise.
2023-12-05 Korean
기타경영사항(자율공시)(국책과제 선정(뼈손실과 관절 염증을 이중 제어하는 혁신적인 치료제 개발))
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) from MedPacto regarding the selection of a government-funded R&D project. It details the project scope, funding, and objectives. Since it does not fit into specific categories like M&A, dividends, or financial reports, and serves as a general regulatory announcement of a business development, it is classified as a Regulatory Filing (RNS).
2023-12-04 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details changes in share ownership, including the addition of a special related party and adjustments to share counts and ratios. This type of filing is a standard regulatory requirement for significant shareholders (often referred to as a 5% report or major shareholding notification) and falls under the 'Major Shareholding Notification' category.
2023-12-01 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(전이성 결장직장암 환자 대상 백토서팁 키트루다 병용 요법 제2b/3상 미국 FDA 임상 시험 계획 승인신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (MedPacto) announcing the submission of an application for a Phase 2b/3 clinical trial to the US FDA. It follows the standard format for a 'Major Management Matter' (주요경영사항) disclosure in the Korean market, which is used to inform investors of significant corporate developments. Since it does not fit into specific categories like M&A, dividends, or financial reports, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2023-11-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications and changes in special relationships. This falls under the 'Major Shareholding Notification' category.
2023-11-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.